2Wasik A,Song HF, Grimes A, et al. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma[ J ]. Optometry, 2009,80 ( 5 ) :243.
3Sivak-Callcott JA, O' Day DM, Gass JD, et al. Evidencebased recommendations for the diagnosis and treatment of neovascular glaucoma[ J ]. Ophthalmology ,2001,108 ( 10 ) :1767.
5Liu GJ, Mizukawa A, Okisaka S. Mechanism of intraocular pressure decrease after contact transscleral continuouswave Nd: YAG laser cyclophotocoagulation [ J ]. Ophthalmic Res,1994,26(2) :65.
6Moshfeghi AA, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab(avastin) therapy for neovascular age-related macular degeneration : twenty-four-week results of an uncontrolled, open label clinical study[ J]. Ophthalmology, 2006,113( 11 ) :2002. e1.
7Rosenfeld PJ, Moshfeghi AA, Puliafitoc CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab(avastin) for neovascular age-related macular degeneration [ J ]. Ophthalmic Surg Laser Imaging, 2005,36(4) :331.
8Iliev ME, Domig D, Wolf-Schnurrbursch U, et al. Intravitral bevacizumab (Avastin) in the treatment of neovasculat glaucoma [ J ]. Am J Ophthalmol,2006,142 (6) : 1054.
3Egbert PR, Fiadoyor S, Budenz DL, et al. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma[ J ]. Arch Ophthalmol, 2001,119(3 ) :345
4Hauber FA, Scherer WJ. Influence of total energy delivery on success rate after contact diode laser transscleral cyclophotocoagulation : a retrospective case review and meta-analysis [ J ]. J Glaucoma, 2002,11 ( 4 ) : 329
5Noureddin BN, Zein W,Haddad C,et al. Diode laser transcleral cyclophotocoagulation for refractory glaucoma: a 1 year follow-up of patients treated using an aggressive protocol[ J]. Eye ,2006,20( 3 ) :329
6Schlote T, Derse M. Subconjunctival anesthesia in contact diode laser cyclophotocoagulation[ J]. Ophthalmic Surg Lasers, 2001,32(4) :289
7Gaasterland DE, Pollack IP. Initial experience with a new method of laser transscleral cyclopotocoagulation for ciliary ablation in severe glaucoma [ J ]. Trans Am Ophthalmol Soc, 1992,90:225
8McKelvie PA, Walland MJ. Pathology of cyclodiode laser:a series of nine enucleated eyes [ J ]. Br J Ophthalmol, 2002,86(4) :381
9[1]Hawkins TA, Stewart WC. One-year result of semiconductor transscleral cyclophotocoagulation in patients with glaucoma[J]. Arch Ophthalmol 1993;111∶488-491.
10[2]Simmons RB, Prum BE, Sheilds SR, Echelman DA, Shield MB. Videographic and histologic comparison of Nd∶YAG and diode laser contact transscleral cyclophotocoagulation[J]. Am J Ophthalmol 1994;117∶337-341.
8Barton K, Gedde SJ, Budenz DL, et al. The Ahmed Baerveldt Comparison Study methodology, baseline patient characteris- tics, and intraoperative complications [ J ]. Ophthalmology, 2011,118(3) :435.
9Sasamoto Y, Oshima Y, Miki A, et al. Clinical outcomes and changes in aqueous vascular endothelial growth facfor levels after intravitreal bevacizumab for iris neovascularization and- neovascular glaucoma: a retrospective two-dose comparative study[ J]. J Ocul Pharmacol Ther,2012,28( 1 ):41.
10Chang JH, Garg NK, Lunde E, et al. Corneal neovascu- larization: an anti-VEGF therapy review[ J]. Surv Ophthal- mol,2012,57 (5) :415.
